Yufeng Xie

1.2k total citations · 1 hit paper
38 papers, 923 citations indexed

About

Yufeng Xie is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Yufeng Xie has authored 38 papers receiving a total of 923 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 20 papers in Oncology and 11 papers in Cancer Research. Recurrent topics in Yufeng Xie's work include Immunotherapy and Immune Responses (8 papers), CAR-T cell therapy research (8 papers) and Cancer Research and Treatments (6 papers). Yufeng Xie is often cited by papers focused on Immunotherapy and Immune Responses (8 papers), CAR-T cell therapy research (8 papers) and Cancer Research and Treatments (6 papers). Yufeng Xie collaborates with scholars based in China, Canada and United States. Yufeng Xie's co-authors include Xiumin Zhou, Min Tao, Deng‐Guang Yu, Yiru Xia, Jim Xiang, Dongqin Chen, Zhengyuan Yu, Jie Wu, Rongrui Liang and Min Tao and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and Journal of Medicinal Chemistry.

In The Last Decade

Yufeng Xie

37 papers receiving 917 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Electrospun trilayer eccentric Janus nanofibers for a combined treatment of periodontitis

2024 84 citations Yiru Xia, Deng‐Guang Yu et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yufeng Xie China	19	473	282	261	215	125	38	923
Linda T. Senbanjo United States	8	453 1.0×	142 0.5×	249 1.0×	141 0.7×	94 0.8×	11	908
Maohua Cai China	15	417 0.9×	133 0.5×	267 1.0×	227 1.1×	70 0.6×	19	854
Hai Hu China	18	666 1.4×	245 0.9×	551 2.1×	222 1.0×	190 1.5×	33	1.3k
Hamed Manoochehri Iran	16	392 0.8×	237 0.8×	216 0.8×	114 0.5×	66 0.5×	52	945
Fenglei Wu China	18	520 1.1×	273 1.0×	283 1.1×	300 1.4×	154 1.2×	33	1.1k
Yan Du China	19	654 1.4×	154 0.5×	425 1.6×	234 1.1×	67 0.5×	35	1.2k
Jason T. George United States	16	531 1.1×	296 1.0×	463 1.8×	137 0.6×	95 0.8×	35	1.0k
Guangchao Xu China	15	359 0.8×	126 0.4×	229 0.9×	128 0.6×	60 0.5×	39	750
Tingbo Liang China	13	503 1.1×	358 1.3×	343 1.3×	254 1.2×	115 0.9×	33	1.1k
Guannan Wang China	15	844 1.8×	488 1.7×	283 1.1×	149 0.7×	110 0.9×	30	1.3k

Countries citing papers authored by Yufeng Xie

Since Specialization

Citations

This map shows the geographic impact of Yufeng Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yufeng Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yufeng Xie more than expected).

Fields of papers citing papers by Yufeng Xie

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yufeng Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yufeng Xie. The network helps show where Yufeng Xie may publish in the future.

Co-authorship network of co-authors of Yufeng Xie

This figure shows the co-authorship network connecting the top 25 collaborators of Yufeng Xie. A scholar is included among the top collaborators of Yufeng Xie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yufeng Xie. Yufeng Xie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shao, Chenye, Xin Tong, Li Yu, et al.. (2025). Organoid‐based two‐step drug screening for rapid identification of chemotherapy‐resistant oesophageal squamous cell carcinoma and alternative therapies. Clinical and Translational Medicine. 15(11). e70534–e70534.

Bai, Yiling, Zhaojia Wu, Scot C. Leary, et al.. (2025). Focal Adhesion Kinase Alleviates Simulated Microgravity-Induced Inhibition of Osteoblast Differentiation by Activating Transcriptional Wnt/β-Catenin-BMP2-COL1 and Metabolic SIRT1-PGC-1α-CPT1A Pathways. International Journal of Molecular Sciences. 26(4). 1669–1669. 2 indexed citations

Zhang, Zhiyuan, et al.. (2024). Electrospun chitosan//ethylcellulose-vitamin E//ethylcellulose-curcumin tri-chamber eccentric Janus nanofibers for a joint antibacterial and antioxidant performance. International Journal of Biological Macromolecules. 281(Pt 2). 135753–135753. 31 indexed citations

Zeng, Weibiao, Jin Wang, Zhike Chen, et al.. (2024). Efficient Predictor for Immunotherapy Efficacy: Detecting Pan‐Clones Effector Tumor Antigen‐Specific T Cells in Blood by Nanoparticles Loading Whole Tumor Antigens. Advanced Science. 12(2). e2409913–e2409913. 3 indexed citations

Zhu, Chuandong, Yufeng Xie, Qiang Li, et al.. (2023). CPSF6-mediated XBP1 3’UTR shortening attenuates cisplatin-induced ER stress and elevates chemo-resistance in lung adenocarcinoma. Drug Resistance Updates. 68. 100933–100933. 45 indexed citations

Li, Dongbao, Yunliang Wang, Anqi Dong, et al.. (2023). Loss of NDUFS1 promotes gastric cancer progression by activating the mitochondrial ROS-HIF1α-FBLN5 signaling pathway. British Journal of Cancer. 129(8). 1261–1273. 13 indexed citations

Wang, Jinghan, Ying Wang, Qian Gao, et al.. (2021). MiR‐378a‐3p as a putative biomarker for hepatocellular carcinoma diagnosis and prognosis: Computational screening with experimental validation. SHILAP Revista de lepidopterología. 11(2). e307–e307. 18 indexed citations

Zhao, Jing, Qiang Li, Dapeng Li, et al.. (2020). Effect of microwave ablation treatment of hepatic malignancies on serum cytokine levels. BMC Cancer. 20(1). 812–812. 23 indexed citations

Zhao, Yingying, Ruifang Chen, Qian Gao, et al.. (2020). Sirtuin 7 promotes non‑small cell lung cancer progression by facilitating G1/S phase and epithelial‑mesenchymal transition and activating AKT and ERK1/2 signaling. Oncology Reports. 44(3). 959–972. 19 indexed citations

10.

Chen, Qing, et al.. (2019). Screening and identification of hub genes in pancreatic cancer by integrated bioinformatics analysis. Journal of Cellular Biochemistry. 120(12). 19496–19508. 20 indexed citations

11.

Xie, Yufeng, Jie Wu, Aizhang Xu, et al.. (2018). Heterologous human/rat HER2-specific exosome-targeted T cell vaccine stimulates potent humoral and CTL responses leading to enhanced circumvention of HER2 tolerance in double transgenic HLA-A2/HER2 mice. Vaccine. 36(11). 1414–1422. 25 indexed citations

12.

Peng, Li, Yufeng Xie, Chenguang Wang, et al.. (2017). MOXIBUSTION ALLEVIATES GASTRIC PRECANCEROUS LESIONS IN RATS BY PROMOTING CELL APOPTOSIS AND INHIBITING PROLIFERATION-RELATED ONCOGENES. African Journal of Traditional Complementary and Alternative Medicines. 14(2). 148–160. 6 indexed citations

13.

Yin, Hao, Xiaoxiao Huang, Min Tao, et al.. (2017). Adenovirus-mediated TIPE2 overexpression inhibits gastric cancer metastasis via reversal of epithelial–mesenchymal transition. Cancer Gene Therapy. 24(4). 180–188. 24 indexed citations

14.

Wu, Jie, Haitao Zhang, C. F. Xu, et al.. (2015). TIPE2 functions as a metastasis suppressor via negatively regulating β-catenin through activating GSK3β in gastric cancer. International Journal of Oncology. 48(1). 199–206. 29 indexed citations

15.

Mao, Yixiang, Wei Li, Kai Chen, et al.. (2014). B7-H1 and B7-H3 are independent predictors of poor prognosis in patients with non-small cell lung cancer. Oncotarget. 6(5). 3452–3461. 108 indexed citations

16.

Xie, Yufeng, Y Chen, Khawaja Ashfaque Ahmed, et al.. (2013). Potent CD4+ T-cell epitope P30 enhances HER2/neu-engineered dendritic cell-induced immunity against Tg1-1 breast cancer in transgenic FVBneuN mice by enhanced CD4+ T-cell-stimulated CTL responses. Cancer Gene Therapy. 20(10). 590–598. 16 indexed citations

17.

Xie, Yufeng, Lu Wang, Andrew Freywald, et al.. (2012). A novel T cell-based vaccine capable of stimulating long-term functional CTL memory against B16 melanoma via CD40L signaling. Cellular and Molecular Immunology. 10(1). 72–77. 31 indexed citations

18.

Chen, Y, Yufeng Xie, Tim Hon Man Chan, et al.. (2011). Adjuvant effect of HER-2/neu-specific adenoviral vector stimulating CD8+ T and natural killer cell responses on anti-HER-2/neu antibody therapy for well-established breast tumors in HER-2/neu transgenic mice. Cancer Gene Therapy. 18(7). 489–499. 10 indexed citations

19.

Li, Zhengyi, Yufeng Xie, Weihua Sheng, et al.. (2010). Tumor-Suppressive Effect of Adenovirus-Mediated Inhibitor of Growth 4 Gene Transfer in Breast Carcinoma Cells In Vitro and In Vivo. Cancer Biotherapy and Radiopharmaceuticals. 25(4). 427–437. 18 indexed citations

20.

Su, Yan, Haifeng Zhang, Yufeng Xie, et al.. (2009). Recombinant Human Interleukin-24 Suppresses Gastric Carcinoma Cell GrowthIn VitroandIn Vivo. Cancer Investigation. 28(1). 85–93. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact